Leucocyte migration inhibition response to tissue antigens in asymptomatic individuals infected with Trypanosoma

The direct leucocyte migration inhibition test was used to study 31 asymptomatic humans chronically infected with Trypanosoma cruzi and 23 normal uninfected controls. The antigenic preparations used were made from mouse and guinea-pig heart, skeletal muscle, kidney, liver and brain. Positive responses were found in the parasite-infected individuals to kidney, liver and brain antigen but not to antigen prepared from heart of skeletal muscle tissue. No correlation was found between T. cruzi antibody titres and migration index values to these various antigens. On the other hand, a positive correlation was only noted between the titres of tissue-reacting immunoglobulins and the migration indices induced by brain antigens: when titres of tissue-reacting immunoglobulins were elevated, less leucocyte migration inhibition was detected.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...